NEW YORK (GenomeWeb) – Next-generation sequencing data firm OneOme has raised $1 million toward a targeted $5 million private financing round, it said in a document filed with the US Securities and Exchange Commission this week. 

The company said 15 investors had participated in the round but did not disclose their identities. OneOme CEO Troy Kopischke told GenomeWeb that the financing is the firm's first seed round and will help it accelerate the growth of its pharmacogenomics platform. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.